top of page

KLUS Pharma to attend 2023 ASCO Annual Meeting

KLUS Pharma will attend 2023 ASCO Annual Meeting in Chicago from June 2-6th.

KLUS Pharma is the US subsidiary of Kelun-Biotech, a mid-sized innovative biopharma company based in Chengdu, China. Kelun-Biotech is committed to the development of innovative therapies to address the unmet needs of patients with advanced cancer and other serious illnesses. Currently, we are advancing several antibody-drug conjugates (ADCs) and immuno-oncology assets in ongoing clinical trials for advanced solid tumors, including lung, breast, gastric, and others. We are excited to share recent progress and review the latest data updates being presented at ASCO and look forward to meeting potential collaborators and colleagues!

Business Development Team

Saturday, May 27, 2023

bottom of page